相关实验视频

Updated: Jan 8, 2026

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
09:33

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

Published on: December 26, 2016

8.3K

在阿尔茨海默氏症中CD33和TREM2之间的相互作用:潜在的机械洞察力在粉样细胞病理中的微质功能

Elizabeth T Akinluyi1, Kei Takahashi-Yamashiro1,2, Meghan G Connolly1

  • 1Department of Chemistry, University of Alberta, Edmonton T6G 2G2, Canada.

ACS chemical neuroscience
|December 13, 2025
PubMed
概括

阿尔茨海默病涉及微质,大脑免疫细胞. 研究人员正在探索CD33和TREM2基因如何相互作用以影响阿尔茨海默病风险和针对这些途径的潜在治疗方法.

关键词:
阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.在Aβ的斑块上,Aβ的斑块形成.CD3333 CD3333 CD3333 CD3333 CD33 CD33 CD33 CD33 CD33 CD33 CD33 CD33 CD33 CD33 CD33 CD33 CD33 CD33 CD33在TREM2中,我们可以使用TREM2.微质细胞中的微质细胞化糖甘是一种

更多相关视频

Correlative Light and Electron Microscopy to Study Microglial Interactions with β-Amyloid Plaques10:52

Correlative Light and Electron Microscopy to Study Microglial Interactions with β-Amyloid Plaques

Published on: June 1, 2016

11.9K
Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease04:22

Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease

Published on: May 20, 2024

1.3K

相关概念视频

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
752